Ivar Sønbø Kristiansen

发表

[Evaluation of medical methods--can we rely on cost-benefit-analysis?].

Kjeld Møller Pedersen, Ivar Sønbø Kristiansen, Knut Stavem, 2003, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[Prioritization is more than regulation of waiting list].

Ivar Sønbø Kristiansen, 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Future health care costs--do health care costs during the last year of life matter?

Ivar Sønbø Kristiansen, I. Kristiansen, Jannie Madsen, 2002, Health policy.

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave

Ivar Sønbø Kristiansen, Birgitte Freiesleben de Blasio, I. Kristiansen, 2010, BMC public health.

Dynamic modelling of costs and health consequences of school closure during an influenza pandemic

Ivar Sønbø Kristiansen, Birgitte Freiesleben de Blasio, I. Kristiansen, 2012, BMC Public Health.

Learning effects in time trade-off based valuation of EQ-5D health states.

Kim Rand-Hendriksen, Ivar Sønbø Kristiansen, Knut Stavem, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Evidence-based medicine, in its place

Ivar Sønbø Kristiansen, I. Kristiansen, Gavin Mooney, 1995, The Lancet.

Decisions on drug therapies by numbers needed to treat: a randomized trial.

Ivar Sønbø Kristiansen, I. Kristiansen, P. Halvorsen, 2005, Archives of internal medicine.

Primary care physicians’ adoption of new drugs is not associated with their clinical interests: A pharmacoepidemiologic study

Jens Søndergaard, Ivar Sønbø Kristiansen, Morten Andersen, 2011, Scandinavian journal of primary health care.

Effects of baseline risk information on social and individual choices.

Jesper Bo Nielsen, Dorte Gyrd-Hansen, Jørgen Nexøe, 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial.

Jesper Bo Nielsen, Dorte Gyrd-Hansen, Jørgen Nexøe, 2002, Journal of clinical epidemiology.

Number-needed-to-treat (NNT)--needs treatment with care.

Ivar Sønbø Kristiansen, I. Kristiansen, P. Christensen, 2006, Basic & clinical pharmacology & toxicology.

How Do Individuals Apply Risk Information When Choosing Among Health Care Interventions?

Jesper Bo Nielsen, Dorte Gyrd-Hansen, Jørgen Nexøe, 2003, Risk analysis : an official publication of the Society for Risk Analysis.

A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture.

Kim Brixen, Ivar Sønbø Kristiansen, Morten Andersen, 2003, Clinical therapeutics.

Does the early adopter of drugs exist? A population-based study of general practitioners’ prescribing of new drugs

Jens Søndergaard, Ivar Sønbø Kristiansen, Morten Andersen, 2004, European Journal of Clinical Pharmacology.